HER2 In Breast Cancer: Testing Guidelines and New Treatment Approaches

This CME/CMLE-accredited online course is designed to help Pathologists, laboratory professionals, and other members of the cancer care team apply the latest scientific evidence when evaluating HER2 status and be comfortable having an open dialogue surrounding challenging HER2 cases and how treatment is informed by HER2 status. Faculty also present information about how the emerging science around HER2‐low may impact patient care.

The activity offers 1.0 CME/CMLE credit.

Supported by an independent educational grant from Daiichi Sankyo, Inc.